Anesthetic preconditioning: triggering role of reactive oxygen and nitrogen species in isolated hearts

Am J Physiol Heart Circ Physiol. 2002 Jul;283(1):H44-52. doi: 10.1152/ajpheart.01056.2001.

Abstract

We postulated that anesthetic preconditioning (APC) is triggered by reactive oxygen/nitrogen species (ROS/RNS). We used the isolated guinea pig heart perfused with L-tyrosine, which reacts with ROS and RNS to form strong oxidants, principally peroxynitrite (ONOO(-)), and then forms fluorescent dityrosine. ROS scavengers superoxide dismutase, catalase, and glutathione (SCG) and NO. synthesis inhibitor N(G)-nitro-L-arginine methyl ester (L-NAME) were given 5 min before and after sevoflurane preconditioning stimuli. Drugs were washed out before 30 min of ischemia and 120 min of reperfusion. Groups were control (nontreated ischemia control), APC (two, 2-min periods of perfusion with 0.32 +/- 0.02 mM of sevoflurane; separated by a 6-min period of perfusion without sevoflurane), SCG, APC + SCG, L-NAME, and APC + L-NAME. Effluent dityrosine at 1 min reperfusion was 56 +/- 6 (SE), 15 +/- 5, 40 +/- 5(++), 39 +/- 4(++), 35 +/- 4(++) , and 33 +/- 5(++) units ((++)P< 0.05 vs. APC), respectively; left ventricular pressure (%baseline) at 60 min of reperfusion was 30 +/- 5(++), 60 +/- 4, 35 +/- 5(++), 37 +/- 5(++), 44 +/- 4, and 47 +/- 4; and infarct size (%total heart weight) was 50 +/- 5(++), 19 +/- 2, 48 +/- 3(++), 46 +/- 4(++), 42 +/- 4(++), and 45 +/- 2(++). Thus APC is initiated by ROS as shown by improved function, reduced infarct size, and reduced dityrosine on reperfusion; protective and ROS/RNS-reducing effect of APC were attenuated when bracketed by ROS scavengers or NO* inhibition.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Anesthetics / pharmacology*
  • Animals
  • Coronary Circulation / drug effects
  • Enzyme Inhibitors / pharmacology
  • Guinea Pigs
  • Heart / drug effects*
  • Heart / physiopathology*
  • In Vitro Techniques
  • Ischemic Preconditioning, Myocardial / methods*
  • Methyl Ethers / pharmacology
  • Myocardial Ischemia / physiopathology
  • Myocardial Reperfusion
  • Myocardium / metabolism*
  • Myocardium / pathology
  • NG-Nitroarginine Methyl Ester / pharmacology
  • Nitric Oxide / antagonists & inhibitors
  • Nitric Oxide / metabolism
  • Peroxynitrous Acid / metabolism
  • Reactive Oxygen Species / metabolism*
  • Reperfusion Injury / pathology
  • Reperfusion Injury / physiopathology
  • Reperfusion Injury / prevention & control
  • Sevoflurane
  • Time Factors
  • Tyrosine / analogs & derivatives*
  • Tyrosine / biosynthesis

Substances

  • Anesthetics
  • Enzyme Inhibitors
  • Methyl Ethers
  • Reactive Oxygen Species
  • Peroxynitrous Acid
  • Nitric Oxide
  • Sevoflurane
  • Tyrosine
  • dityrosine
  • NG-Nitroarginine Methyl Ester